ArticleFrontiers in pharmacology2024
Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling.
Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.